돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 279생성일: 2026년 10월 23일

4-Bromophenol → 4-Morpholinophenol

https://huagongshe.com/ko/reaction/279

반응식

참여 물질

역할이름HCID투입량
반응물4-BromophenolHCID 7808—
반응물MorpholineHCID 8083—
시약Sodium t-butoxideHCID 23676156—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
촉매2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
용매TolueneHCID 1140—
생성물4-MorpholinophenolHCID 8051031.25%

반응 조건

온도100 °C

반응 단계

4-Bromophenol (865 mg, 5 mmol), Tris(dibenzylideneacetone)dipalladium(0) (229 mg, 0.25 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (238 mg, 0.50 mmol), Morpholine (0.437 mL, 5.00 mmol) and sodium tert-butoxide (1009 mg, 10.50 mmol) were stirred in toluene (5 mL) overnight at 100 °C. The mixture was allowed to cool to ambient temperature. Ethylacetate was added and the mixture was washed with aqueous NaHCO3 (satd.) and water. The organic phase was separated, dried over MgSO4, filtered and the solvent removed by rotary evaporation. The crude product was added to a silica gel column and was eluted with 0-2 % MeOH in DCM. The collected fraction were combined and the solvent was removed by rotary evaporation. 1H NMR in CDCl3 is consistent with desired product MS (m+1) = 180. HPLC Peak RT = 2.55 minutes is product. Purity = 96%.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-c3c3446fa521406ab3b5349b3ab1378a
출처 메모750 AstraZeneca ELN dataset